Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 4/20 | 0.60 |
| ▸ | ELANE | P08246 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6636032 | 0.93 | CTRB1 (0.59) | CTRB1ELANEKMT2APKMSMN1; SMN2 | |
| SCHEMBL6638871 | 0.89 | ELANE (0.61) | CTRB1ELANEKMT2AMEN1ALDH1A1 | |
| SCHEMBL6722619 | 0.87 | ELANE (0.59) | CTRB1ELANE | |
| SCHEMBL6639790 | 0.87 | CTRB1 (0.59) | CTRB1ELANESMN1; SMN2ALDH1A1HTT | |
| SCHEMBL6636501 | 0.86 | CTRB1 (0.58) | CTRB1ELANEKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL6633866 | 0.86 | CTRB1 (0.53) | CTRB1ELANEKMT2APKMSMN1; SMN2 | |
| SCHEMBL6638186 | 0.85 | CTRB1 (0.62) | CTRB1ELANEKMT2APKMMEN1 | |
| SCHEMBL6635647 | 0.82 | ELANE (0.60) | CTRB1ELANE | |
| SCHEMBL6635955 | 0.82 | ELANE (0.56) | CTRB1ELANEKMT2AMAPTMEN1 | |
| SCHEMBL6639124 | 0.82 | ELANE (0.57) | CTRB1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | claimed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | claimed |
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |